â??AN INVESTIGATOR - INITIATED, PROSPECTIVE, OBSERVATIONAL STUDY TO OBSERVE THE EFFICACY AND SAFETY OF BRINZOLAMIDE 1% OPHTHALMIC SUSPENSION IN SUBJECTS WITH CHRONIC OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSIONâ??

Dr Rajesh Parekh0 个研究点目标入组 20 人开始时间: 待定最近更新: 2021年11月24日

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 20

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Observational

入排标准

入选标准

•Written, signed, dated and ethics committee approved informed consent obtained from subjects and/or legally acceptable representative, before performing any screening procedures
•Male and/or non-pregnant females of age 18 to 65 years [both inclusive] with chronic open angle glaucoma or ocular hypertension in both the eyes on stable ocular hypotensive treatment regimen
•Newly diagnosed or Subjects who require treatment of both the eyes and is able to discontinue use of all ocular hypotensive medication(s) or switch ocular hypotensive medications and undergo appropriate washout period
•Adequate wash-out period prior to baseline of any ocular hypotensive medication (see Table No. 1). In order to minimize potential risk to patients due to IOP elevations during the washout period, investigator may choose to substitute a parasympathomimetic or carbonic anhydrase inhibitor in place of a sympathomimetic, alpha-agonist, beta-adrenergic blocking agent, or prostaglandin; however, all patients must have discontinued all ocular hypotensive medication for the minimum washout period provided in Table No. 1
•Baseline (hour 0) IOP >= 22 mm Hg and <= 34 mm Hg in each eye and any asymmetry of IOP between the eyes which is no greater than 5 mm Hg
•Baseline best corrected visual acuity equivalent to 20/200 or better in each eye

排除标准

•Female who are pregnant, breast feeding or planning a pregnancy
•Female of childbearing potential who do not agree to utilize an adequate form of contraception
•Current or past history of severe hepatic or renal impairment
•Current or history of significant ocular disease within two months prior to baseline e.g., corneal edema, uveitis, ocular infection, or ocular trauma in either eye
•Current corneal abnormalities that would prevent accurate IOP readings with the Goldmann applanation tonometer
•Functionally significant visual field loss
•Contraindication to brinzolamide or sulfonamide therapy or known hypersensitivity to any component of brinzolamide or sulfonamide therapy
•Use of intraocular corticosteroid implant at any time prior to baseline
•Use of contact lens within one week prior to baseline
•Use of: a) topical ophthalmic corticosteroid or b) topical corticosteroid within two weeks prior to baseline
•Use of: a) systemic corticosteroid or b) high-dose salicylate therapy within one month prior to baseline
•Use of intravitreal or subtenon injection of ophthalmic corticosteroid within six months prior to baseline
•Performance of any other intraocular surgery (e.g., cataract surgery) within six months prior to baseline
•Performance of refractive surgery, filtering surgery or laser surgery for IOP reduction within twelve months prior to baseline
•History of alcohol, chemical or drug abuse or dependence as per DSM IV criteria
•Current active malignancy or history of malignancy within the past five years
•Any other clinically significant abnormal medical condition that in the Investigators judgement would put the patient at increased risk of illness or injury would interfere with study participation or would interfere with the evaluation or quality of the data

研究者

发起方

Dr Rajesh Parekh

相似试验

已完成

不适用

PROSPECTIVE, SINGLE ARMSTUDY TO DETERMINE THE SAFETY AND EFFICACY OF TOPICAL DICLOFENAC SODIUM GEL WITH NANOTECHNOLOGY IN SUBJECTSWITH OSTEOARTHRITIS OF KNEE

CTRI/2015/10/006269Mrs Nagalakshmi AnandaPadmanabhan50

尚未招募

Unknown

This is a type of Prospective, Observational, Investigator-initiated Study (IIS) to Investigate the Real-World Effectiveness and Safety of Denosumab in Patients with Osteoporosis due to Chronic Kidney Disease.

CTRI/2024/03/064791Dr Jatin Kothari

已完成

4 期

An Investigator Initiated, Controlled, Prospective, Non-Inferiority, Parallel-Group, randomised, Interventional, Open, Blinded Outcome Assessment (PROBE-Design), Multi-centre Trial, Comparing Efficacy and Safety of Isolation of the Pulmonary Veins with a Cryoballoon Catheter Versus a Radiofrequency Ablation with a ThermoCool Catheter in Patients with Paroxysmal Atrial FibrillatioParoxysmal atrial fibrillationirregular heart beat10007521

NL-OMON39146FGK Representative Service GmbH114

尚未招募

3 期

A research by your doctor to check the use of medicine Enkor-KT against cold and sore throat.

CTRI/2020/05/025098Tenshi LifeCare Pvt Ltd Bengaluru Karnataka

招募中

不适用

AN INVESTIGATOR INITIATED STUDY TO OBSERVE AND EVALUATE THE INCIDENCE OF EGFR MUTATIONS IN ADULT INDIAN PATIENTS WITH NON-SMALL CELL LUNG CANCER

CTRI/2012/05/002665Dr Senthil Rajappa150